NCT05857046View on ClinicalTrials.gov

Cerebroprotective Effect of Melatonin in Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

July 14, 2025

Conditions
Stroke, Acute IschemicStrokes Thrombotic
Interventions
DRUG

Melatonin 10 MG

Patients received extended-release melatonin 10 mg PO every 12 hours for 7 days and then every 24 hours for 83 days

OTHER

Placebo

Patients received placebo every 12 hours for 7 days and then every 24 hours for 83 days

Trial Locations (1)

58290

RECRUITING

Georgina Ortiz-Martínez, Morelia

All Listed Sponsors
collaborator

Instituto Mexicano del Seguro Social

OTHER_GOV

collaborator

Universidad Michoacana de San Nicolás de Hidalgo

UNKNOWN

collaborator

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

OTHER_GOV

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV